Omrix Biopharmaceuticals, Inc. Report issue

Contributed to NME For profit Phase 2 Phase 3
Founded: Qiryat Ono Israel (1995)
Status: Acquired by Johnson and Johnson (2008)

Organization Overview

First Clinical Trial
2004
NCT00196534
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Omrix Biopharmaceuticals | OMRIX Biopharmaceuticals